Effect of delayed treatment with recombinant human granulocyte colony-stimulating factor on survival and plasma cytokine levels in a non-neutropenic porcine model of Pseudomonas aeruginosa sepsis

Shock

Volumn 9, Issue 2, 1998, Pages 128-134

  Haberstroh, Jörg ^a   Wiese, Kai ^a   Geist, Andrea ^a   Dursunoglu, Gülra B ^a   Gippner Steppert, Cornelia ^b   Jochum, Marianne ^b   V Specht, Bernd U ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; IL1RN PROTEIN, HUMAN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RECOMBINANT PROTEIN; SIALOGLYCOPROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BACTEREMIA; BLOOD; BLOOD GAS ANALYSIS; BLOOD PRESSURE; DISEASE MODEL; DRUG EFFECT; GRAM NEGATIVE INFECTION; HEMODYNAMICS; HUMAN; LUNG VENTILATION; MICROBIOLOGY; MORTALITY; SURVIVAL RATE; SWINE; TIME;

ANIMALS; BACTEREMIA; BLOOD; BLOOD GAS ANALYSIS; BLOOD PRESSURE; CYTOKINES; DISEASE MODELS, ANIMAL; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMODYNAMIC PROCESSES; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; PSEUDOMONAS INFECTIONS; PULMONARY VENTILATION; RECOMBINANT PROTEINS; SIALOGLYCOPROTEINS; SURVIVAL RATE; SWINE; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031989190     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199802000-00009     Document Type: Article

References (33)

1. Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: A severity of disease classification system. Crit Care Med 13:818-829, 1985.
2. O'Reilly M, Silver GM, Greenhalgh DG, Gamelli RL, Davis JH, Hebert JC: Treatment of intra-abdominal infection with granulocyte colony-stimulating factor. J Trauma 33:679-682, 1992.
3. Kanazawa M, Ishizaka A, Hasagawa N, Suzuki Y, Yokoyama T: Granulocyte-colony stimulating factor does not enhance endotoxin-induced acute lung injury in guinea pigs. Am Rev Resp Dis 145:1030-1035, 1992.
4. Eichacker PQ, Waisman Y, Natanson C, et al: Cardiopulmonary effects of granulocyte colony-stimulating factor in a canine model of bacterial sepsis. J Appl Physiol 77:2366-2373, 1994.
5. Lorenz W, Reimund PK, Weitzel F, et al: Granulocyte colony-stimulating factor prophylaxis before operation protects against lethal consequences of postoperative peritonitis. Surgery 116:925-934, 1994.
6. Görgen I, Hartung T, Leist M, et al: Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic necrosis factor-α. J Immunol 149:918-924, 1992.
7. Fink MP, O'Sullivan BP, Menconi MJ, et al: Effect of granulocyte colony-stimulating factor on systemic and pulmonary responses to endotoxin in pigs. J Trauma 34:571-578, 1993.
8. Koizumi T, Kubo K, Shinozaki S, Koyama S, Kobayashi T, Sekiguchi M: Granulocyte colony-stimulating factor does not exacerbate endotoxin-induced lung injury in sheep. Am Rev Respir Dis 48:132-137, 1993.
9. Haberstroh J, Breuer H, Lücke I, et al: Effect of recombinant human granulocyte colony-stimulating factor on hemodynamic and cytokine response in a porcine model of Pseudomonas sepsis. Shock 4:216-224, 1995.
10. Bullard KM, Dunn DL: Diagnosis and treatment of bacteremia and intravascular catheter infections. Am J Surg 172(Suppl 6A):13S-19S, 1996.
11. Dietzmann DE, Fischer GW, Schoenknecht FD: Neonatal Escherichia coli septicemia: Bacterial counts in blood. J Pediatr 58:128-132, 1974.
12. Hurly JC: Antibiotic-induced release of endotoxin: A reappraisal. Clin Infect Dis 15:840-854, 1992.
13. Schneider CM, Huzly D, Vetter C, von Specht BU, Daschner FD: Tumor necrosis factor alpha and interleukin 6 release by antibiotic killing of Pseudomonas aeruginosa and Stapphylococcus aureus. Eur J Clin Microbiol Infect Dis 16:467-471, 1997.
14. Nelson S: Role of granulocyte colony-stimulating factor in the immunresponse to acute bacterial infection in the nonneutropenic host: An overview. Clin Infect Dis 18(Suppl 2):197, 1994.
15. Roilides E, Walsh THJ, Pizzo PHA, Rubin M: Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils. J Infect Dis 163:579-583, 1991.
16. Smith WS, Sumnicht GE, Sharpe RW, Samuelson D, Millard FE: Granulocyte colony-stimulating factor versus placebo in addition to penicillin G in a randomized blinded study of Gram-negative pneumonia sepsis: Analysis of survival and multi organ failure. Blood 86:1301-1309, 1995.
17. Toda H, Murata A, Matsuura N, et al: Therapeutic efficacy of granulocyte colony stimulating factor against rat cecal ligation and puncture model. Stem Cells 11:228-234, 1993.
18. Lundblad R, Nesland JM, Giercksky KE: Granulocyte colony-stimulating factor improves survival rate and reduces concentrations of bacteria, endotoxin, tumor necrosis factor, and endothelin-1 in fulminant intraabdominal sepsis in rats. Crit Care Med 24:820-826, 1996.
19. Bensinger WI, Price TH, Dale DC, et al: The effect of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukopheresis. Blood 81:1883-1888, 1993.
20. Gross-Weege W, Weiss M, Schneider M, et al: Safety of a low-dosage Filgastrim (rhG-CSF) treatment in non-neutropenic surgical intensive care patients with an inflammatory process. Intensive Care Med 23:16-22, 1997.
21. Pruitt JH, Welborn MB, Edwards PD, et al: Increased soluble interleukin-1 type II receptor concentrations in postoperative patients and patients with sepsis syndrome. Blood 87:3282-3288, 1996.
22. Seckinger P, Lowenthal JW, Williamson K, Dayer JM, MacDonald HR: A urine inhibitor of interleukin-1 activity blocks ligand binding. J Immunol 139:1546-1549, 1987.
23. Dayer-Metroz MD, Wollheim CB, Seckinger P, Dayer JM: A natural interleukin-1 (IL-1) inhibitor counteracts the inhibitory effect of IL-1 on insulin production in cultured rat pancreatic islets. J Autoimmun 2:163-171, 1989.
24. Andersson J, Björk L, Dinarello CA, Towbin H, Andersson U: Lipopolysaccharide induces human interleukin-1 receptor antagonist and interleukin-1 production of the same cell. J Immunol 22:2617-2623, 1992.
25. Kaushansky K, Lin N, Adamson JW: Interleukin 1 stimulates fibroblasts to synthesize granulocyte-macrophage and granulocyte colony-stimulating factors: Mechanism for the hematopoietic response to inflammation. J Clin Invest 81:92-97, 1988.
26. Simms HH, D'amico R: Intra-abdominal sepsis alters tumor necrosis factor- and interleukin-1 binding to human neutrophils. Crit Care Med 20:11-16, 1992.
27. Shieh JH, Peterson RHF, Moore MAS: Granulocyte colony-stimulating factor modulation of cytokine receptors on murine bone marrow cells: In vivo and in vitro studies. J Immunol 147:2984-2990, 1991.
28. Mancilla J, Garcia P, Dinarelo CA: The interleukin-1 receptor antagonist can either reduce or enhance the lethality of Klebsiella pneumoniae sepsis in newborn rats. Infect Immunol 61:926-932, 1993.
29. Hirsch E, Irikura VM, Paul SM, Hirsh D: Function of interleukin-1 receptor antagonist in gene knockout and overproducing mice. Proc Natl Acad Sci USA 93:11008-11013, 1996.
30. Parsons PE, Moss M, Vannice JL, Moore EE, Moore FA, Repine JE: Circulating IL-1ra and IL-10 levels are increased but do not predict the development of acute respiratory distress syndrome in at-risk patients. Am J Respir Crit Care Med 155:1469-1473, 1997.
31. Shalaby MR, Palladino MA, Hirabayashi SE, et al: Receptor binding and activation of polymorphonuclear neutrophils by tumor necrosis factor-alpha. J Leukocyte Biol 41:196-204, 1987.
32. Blanchard DK, Friedman H, Klein TW, Djeu JY: Induction of interferon-[gamma] and tumor necrosis factor by Legionella pneumophilia: Augmentation of human neutrophil bactericidal activity. J Leukocyte Biol 45:538-545, 1989.
33. Terashima T, Soejima K, Waki Y, et al: Neutrophils activated by granulocyte colony-stimulating factor suppress tumor necrosis factor-release from monocytes stimulated by endotoxin. Am J Respir Cell Mol Biol 13:69-73, 1995.